Ann: WHA Secures Second Brand Slot for CFDA Accreditation, page-19

ur fact is truth，however，the chinese market can not be satisfied by the existing product for now。Im saying this because I know how large the chinese market is。 Lived in China
For short term players，this may not be the best time get in imo。
but for long term players，still have reason to come in。
reasons such as 1.waiting for several more approvements from CFDA （specially the infant formula one we r waiting）2. sales report coming （sales number definetely increase because of the previous agreement）

trying to be objective，all investment has risk。1.infant formula reject by CFDA
2.sales report go failure

one in fact，CFDA never reject any approval till now
one imo，it is so impossible for a import formula fail to sell in China because the demand is just undescribal huge and WHA have the good production，management is OK

SP may go south several times to dilute the overbought pressure，can not be under 1.6 any more，once the report comes out at the end of this month，SP will be stable upper 2.0

All imo，may be not correct at all，just sharing